Report
Martin Marandon-Carlhian ...
  • Stephane Houri

VAT Group AG : Q1 sales and Q2 guidance slightly below expectations, but solid order intake confirming the recovery of the semi segment

>Q1 2024 sales slightly below the consensus but orders above - This morning, VAT reported Q1 2024 sales slightly below the consensus but with better-than-expected order intake. Sales in Q1 were CHF 199m (down 15% y-o-y and -11% q-o-q), 2% below the company-compiled consensus at CHF 203m (vs a guidance range of CHF 185 – 205m). Orders came in at CHF 236m, above the consensus forecast of CHF 214m. Order intake was up 73% y-o-y and flat q-o-q, with a book-to-bill ratio ...
Underlying
VAT Group AG

VAT Group AG is a Switzerland-based company engaged in the manufacture of industrial valves. The Company focuses on designing and producing vacuum valves for semiconductor, display and solar panel manufacturing, as well as for a range of industry and research applications. Its activities are divided into three business areas: Valves, Global Services and Industry. The Valves division provides isolation, control and transfer valves used in vacuum-based manufacturing processes. The Global Services area offers advisory and after sales services, such as trainings, equipment repair and overhaul, valve upgrade and spare parts sale. The Industry segment manufactures and markets welded bellows, machine parts, mechanical components and assemblies. The Company operates worldwide.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Martin Marandon-Carlhian

Stephane Houri

Other Reports on these Companies
Other Reports from Oddo BHF
Bruno Cavalier
  • Bruno Cavalier
Bruno Cavalier
  • Bruno Cavalier
Matthias Desmarais
  • Matthias Desmarais

ResearchPool Subscriptions

Get the most out of your insights

Get in touch